Tag: Cancer: Kidney
Obesity May Up Survival in Metastatic Renal Cell Carcinoma
Obese/overweight patients survived 25.6 months, compared to 17.1 months for normal-weight patients
Active Surveillance Prior to Systemic Tx Feasible in Renal CA
Shorter surveillance period for those with more IMDC adverse risk factors, more metastatic disease sites
Metabolic Factors May Contribute to Tx Resistance in Renal Cancer
Genes involved in metabolic and solute transport function linked to treatment failure in PD-L1+ RCC
X-Rays Have Low Diagnostic Yield for Pulmonary Metastases
Findings in patients treated for T1a renal cell carcinoma followed with X-ray surveillance
Laparoscopic Nephrectomy Feasible As Outpatient Surgery
Most patients discharged home within first six hours after surgery; none readmitted
Patient Experience Linked to Urologic CA Surgical Outcomes
Less prolonged hospitalization, fewer nursing-sensitive complications in high-performing hospitals
Percutaneous Needle-Based OCT Differentiates Renal Masses
Significantly lower median µOCT for oncocytoma versus renal cell carcinoma
Continued Aspirin Treatment Safe With Partial Nephrectomy
Findings among patients on chronic antiplatelet therapy for cardioprotection
Core-Needle Biopsy Effective in Evaluation of Renal Masses
Image-guided testing of tissue from the renal mass may lead to improved treatments, researchers say
Oncocytomas Tend to Grow Slowly Over Time
Growth does not seem to indicate malignancy; active surveillance seems safe
